MarketWatch
US · 15 mins ago
Major drugmaker loses $27 billion in market value after failed trial
Two companies announced on Thursday that the heart disease drug they had been developing failed its Phase III trial.
Do you trust MarketWatch?
Sign in to rate
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!